RNA interference agent plozasiran targets APOC3 for effective mixed hyperlipidemia treatment

  • Post author:
  • Post category:uncategorized

Researchers evaluate the efficacy of plazosiran treatment on fasting triglyceride levels in adult patients with mixed hyperlipidemia.